Case Report 2
A 37-year old man presented to the hyperacute stroke unit with sudden onset left-sided weakness and sensory disturbance. He had no significant past medical history, except that over the past three months he had been feeling non-specifically unwell with intermittent fevers and night sweats. He had attributed these symptoms to a viral infection, which was prevalent in staff and pupils in the school in which he worked as a teacher. GP records indicated that a blood test two months previously had shown an elevated CRP of 96mg/L and deranged liver function tests, but examination had revealed no explanation for these findings. When admitted to the stroke unit he had left hemiparesis and sensory loss; a systolic murmur was audible on examination. Admission blood tests showed raised CRP at 66mg/L, with a normal white cell count. CT head showed an intracerebral haemorrhage in the right frontal lobe ( of the viridans streptococci group, which is present in dental plaque. He was treated with intravenous antibiotics for 6 weeks, and subsequently had a mitral valve repair.
DISCUSSION
Cerebral complications occur in up to 55% of patients with infective endocarditis, often before the diagnosis of infective endocarditis is made, and include stroke, brain abscess and meningoencephalitis. [1] [2] [3] . In-hospital case fatality of infective endocarditis is about 20%, 1 and is even higher with neurological involvement. Stroke is the commonest neurological complication, and occurs in about 35% of cases of infective endocarditis; a further 30% have "silent" cerebrovascular lesions (iscahemic or hemorrhagic) detectable on MRI. 2 Both symptomatic ischaemic stroke and intracerebral haemorrhage occur, the latter sometimes associated with a demonstrable mycotic aneurysm. Mortality from stroke due to infective endocarditis seems to be higher in patients with prosthetic heart valves, intracerebral hemorrhage, Staphylococcus aureus infection, advanced age, cardiac complications, emergency heart surgery, and septic shock.
Diagnosis of endocarditis in patients with stroke
Infective endocarditis has a highly variable clinical presentation, which may be acute and rapidly progressive, or may have a longer and non-specific prodrome. An acute presentation of infective endocarditis with fevers and congestive heart failure is more easily recognized than a more insidious sub-acute presentation.
The non-specific preceding systemic symptoms in both of our cases -initially attributed to alternative diagnoses -are key to alerting clinicians to the possibility of subacute infective endocarditis as a cause of an acute stroke. It is particularly important that clinicians specifically ask about preceding systemic prodromal symptoms when faced with any unexplained stroke (for example a younger patient with no known vascular risk factors, as in our second case).
These symptoms are often non-specific; fevers and rigors/chills are most common, but weight loss, poor appetite, night sweats, headache, general malaise, cough, myalgia and joint pains can all occur. Infective endocarditis should be suspected in any patient with unexplained stroke who has fever (especially with bacteraemia), cardiac risk factors (previous infective endocarditis, valvular heart disease including congenital heart disease, or a prosthetic valve), or non-cardiac risk factors (intravenous drug use, immunosuppression, or a recent dental or surgical procedure). and Roth spots (haemorrhagic, oedematous lesions of the retina with pale centres). Janeway lesions are presumed embolic phenomena, whereas Osler nodes and Roth spots are thought to be immunological in origin. These classical findings are highly specific, but not very common (Table 1) . Splinter haemorrhages are not so specific, especially if only one or two are found.
Furthermore, the peripheral signs due to systemic embolism can be absent in solely right heart infection, which includes intravenous drug users or those with very acute infection. Although fever is nearly always present in infective endocarditis (in one large study over 95% of patients had a fever >38 degrees 5 ), in acute stroke, fever is often secondary to a complication, for example due to pneumonia, urinary tract infection (UTI), or sepsis, so fever in isolation is not a useful pointer to the possibility of infective endocarditis. Nearly all patients with left heart infective endocarditis have a heart murmur on auscultation, so absence of this sign should lead to questioning the diagnosis; however, murmurs are not so common in right heart infective endocarditis.
Blood inflammatory markers in infective endocarditis are highly sensitive but not very specific, partly because infections often complicate acute stroke; they include elevated erythrocyte sedimentation rate or C-reactive protein. The Duke diagnostic criteria have been validated in pathologically proven infective endocarditis, with sensitivity >80% 8 and almost 100% specificity in patients with acute unexplained fever 9 . The modified Duke criteria give major and minor criteria required for the diagnosis of infective endocarditis (Table 2) 10 : Definite infective endocarditis is diagnosed by:
two major clinical criteria; one major and three minor clinical criteria; or five minor clinical criteria. However, these criteria should always be combined with clinical judgement of the pretest probability. The diagnostic accuracy may be lower in suspected prosthetic valve infective endocarditis, right-sided infective endocarditis, cardiac device infection, and has not been evaluated specifically in patients with acute stroke 11 . Thus, the diagnosis of infective endocarditis in a patient with stroke should not be based entirely on fulfillment of these criteria.
A positive blood culture for an organism compatible with infective endocarditis in a stroke patient should always lead the clinician to review the history and seek out the possible diagnosis of infective endocarditis. There is a high yield from a first blood culture: 96% in streptococcal infective endocarditis and 82% of cases caused by other organisms in one series of 206 cases. 12 In those who are culture negative, fastidious organisms (for example Coxiella,and Bartonella)
should be considered, and the appropriate serologies sent for confirmation 12 
Treatment of stroke associated with infective endocarditis

General treatment
Optimum management of infective endocarditis always requires input from multiple clinical teams; in stroke patients this might need to include neurologists or stroke physicians, cardiologists and cardiothoracic surgeons, neuroradiologists, neurosurgeons, anaesthetists, and microbiology and infectious disease specialists. Antibiotics are the mainstay of treatment and appear to reduce the risk of stroke from 0.5% per day to 0.3% per day 15 . Suggested antibiotic regimens for native and prosthetic valve endocarditis usually include combination intravenous therapy (e.g. amoxicillin and gentamicin for native valve infective endocarditis) but local microbiological expertise is essential. Cardiac valve surgery is needed in about 40-50% of patients with infective endocarditis 16 for three main indications: heart failure due to valve dysfunction, uncontrolled infection, and prevention of embolism. The aims of surgery are to eradicate infection and normalize heart anatomy. Surgery may involve valve repair or bioprosthetic or mechanical replacement; specific evidence for the best approach or optimum timing is not available. In practice, because of concerns about the risks of surgery, anaesthesia and cardiopulmonary bypass, valve surgery is traditionally delayed until patients with infective endocarditis-related stroke are neurologically stable, typically for about two weeks. However, recent data suggests that early surgery might be safe in infective endocarditis 17 18 . A randomized study of early vs. standard timing of surgery found that death from any cause, embolic events, or recurrence of infective endocarditis at 6 months was 3% in the early-surgery group and 28% in the conventional treatment group (hazard ratio, 0.08; 95% CI, 0.01 to 0.65; P=0.02). 17 Current guidelines therefore suggest that after ischaemic stroke, surgery indicated for heart failure, uncontrolled infection, abscess, or persistent high embolic risk should be considered early (ie <14 days), in the absence of severely reduced conscious level or haemorrhage on cranial CT or MRI. 11 In patients with intracranial haemorrhage, neurological prognosis is worse, so it is suggested that surgery should generally be postponed for at least a month. Cardiac surgery typically requires anticoagulation, so particular caution is needed to ensure that intracranial haemorrhage risk is reduced to an acceptable level (e.g. by securing ruptured mycotic aneurysms). In practice, timing is decided by multidisciplinary discussion between the stroke, anaesthetics, cardiology and cardiac surgery teams, and is generally delayed until the patient is neurologically stable.
Ischaemic stroke
Ischaemic stroke is three times more likely than intracranial haemorrhage in infective endocarditis 19 and is attributed to the embolization of infected valve material to the brain. The
risk of neurologic complications has been suggested to be higher in patients with
Staphylococcus aureus infective endocarditis, and with multiple valve involvement. The risk of stroke might be higher with mitral than aortic valve involvement. 12, 20 Intravenous thrombolysis is the standard acute treatment for ischaemic stroke patients presenting within 4.5 hours, but probably carries more hazard than benefit in ischaemic stroke due to infective endocarditis. Intracerebral bleeding in infective endocarditis could occur from either haemorrhagic transformation of an infarct, rupture of an aneurysm, or from a friable inflamed blood vessels due to associated arteritis. The risk of post-thrombolysis intracranial haemorrhage has been reported to be higher in infective endocarditis related ischaemic stroke than in other patients (in one sample of 222 patients the rate of post-thrombolysis intracerebral haemorrhage in infective endocarditis-related ischaemic stroke was 20%, compared to 6.5% in patients with ischaemic stroke unrelated to infective endocarditis). 21 Moreover, there was a significantly lower rate of favourable outcome in the infective endocarditis group (10% versus 37%; P=0.01). Thus, it is likely that this large absolute increase in intracerebral haemorhage risk outweighs the absolute benefit of treatment in most cases of ischaemic stroke associated with infectious endocarditis. However, only a randomized trial could definitively prove that there is no net benefit from alteplase in stroke due infective endocarditis. Given the rarity of endocarditis related ischaemic stroke, such a trial is not feasible, so clinicians must make an informed judgement based on the observational evidence. In our practice, we try to avoid systemic thrombolysis in ischaemic stroke due to infective endocarditis. An alternative treatment for some patients might be endovascular clot retrieval treatment (thrombectomy), which has recently been shown to be dramatically effective in anterior circulation large vessel occlusion; 22 this option is a theoretically attractive option in ischaemic stroke due to infective endocarditis, but has not been evaluated in clinical trials or observational studies in this specific setting. Furthermore, thrombectomy might have higher risks in infective endocarditis than in the trial populations studied, and cannot currently be routinely offered in all stroke centres.
A key clinical challenge is in recognizing the possibility of infectious endocarditis in the very short time window available for effective intravenous thrombolysis in acute ischaemic stroke: (which might be reduced by anticoagulation) with the risk of intracranial haemorrhage (which might be aggravated). In general, there is no evidence to support the use of anticoagulants or antiplatelet drugs in acute stroke due to infective endocarditis so these should be avoided in the acute phase in the absence of any compelling indication; intra-cardiac thrombus, atrial fibrillation or venous thromboembolism might be indications for early anticoagulation. The specific question of whether to continue anticoagulants in patients with prosthetic valve endocarditis remains unsettled, and no general recommendation can be made; the decision needs to individualized, taking account of all available clinical, laboratory and imaging information. Following infective endocarditis-associated ischaemic stroke with a strong indication for anticoagulation it is generally reasonable to delay this by 2 weeks, as is conventional for other patients with cardioembolic stroke. An urgent priority in infective endocarditis patients at risk of intracerebral haemorrhage is cardiological assessment of valve function, and cerebral angiography to look for mycotic aneurysms as these may be amenable to intervention, rather than early anticoagulation; this should allow anticoagulation and other acute decisions to be based on an informed estimate of the competing risks. In particular this information is vital to allow planning of valve surgery, if required.
Intracerebral haemorrhage
Intracerebral haemorrhage occurs in approximately 5% of patients with infective endocarditis and is thought to be due to haemorrhagic transformation of infarcted brain, septic arteritis and vessel wall rupture, or rupture of a mycotic aneurysm 23 . Mycotic aneurysms in infective endocarditis are most frequently found in distal branches of the middle cerebral artery territory.
Patients with Staphylococcus aureus bacteraemia are more likely to develop intracerebral haemorrhage in the first 48 hours after hospital admission. The mortality from ruptured mycotic aneurysms has been reported to be as high as 80%. The rebleeding risk of ruptured mycotic aneurysms is likely to be high, and all should therefore be considered for endovascular or surgical treatment. Clipping may be technically difficult due to an often poorly defined aneurysmal neck and vascular fragility Endovascular therapy (coiling or acrylic glue) may be more appropriate, especially in patients who are unfit for surgery due to cardiac disease. Indeed, surgical treatment of a mycotic aneurysm is a viable option in very few patients -one series of 179 patients with infective endocarditis-related intracerebral haemorrhage found only 2.2% of patients who could be surgically treated. 23 The risk of bleeding from unruptured mycotic aneurysms is unknown, and patients are not routinely offered treatment for this reason.
In conclusion, infective endocarditis is a diagnostic and management challenge in the context of acute ischaemic stroke and intracerebral haemorrhage. The diagnosis of infective endocarditis has important implications for management, which remains challenging due to a lack of prospective controlled studies. We emphasize the importance of a multidisciplinary collaborative approach to give the best outcomes in this devastating disease.
Key Learning points
 Diagnosing infective endocarditis in patients with stroke is challenging but important: in ischaemic stroke due to infective endocarditis, systemic thrombolysis carries a high bleeding risk and is probably best avoided; endovascular treatment is an alternative for large vessel anterior occlusions, though not tested in this specific setting The diagnosis of infective endocarditis is definite with: one pathological criterion; two major criteria; one major and three minor criteria; or five minor criteria
Pathological criteria
Microorganisms 
